These results were consistent with previous studies in a murine model of Alzheimer's disease, in which IGF2 infusion increased the population of DCX+ cells in the adult hippocampus through stimulation of NGF, BDNF, NT3 and IGF1 (Mellott et al., 2014). Here, IGF2 is linked to early-onset autosomal dominant Alzheimer disease.